Pacific Biosciences Of California | PACB - Le Coût Des Ventes





Le Coût Des Ventes Changement Date
Agilent USD 845M 7M 2026-03
Bruker USD 443.6M 84.4M 2026-03
Danaher USD 2.36B 512M 2026-03
General Electric Aerospace USD 8.15B 764M 2026-03
Illumina USD 370M 30M 2026-03
Myriad Genetics USD 63M 1.1M 2025-12
Pacific Biosciences Of California USD 28.9M 10M 2025-12
Quidel USD -79.5M 528.3M 2026-03
Revvity USD 323.46M 26.93M 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
Standard Biotools USD 12.41M 2.34M 2025-12
Thermo Fisher Scientific USD 6.96B 620M 2026-03
Waters USD 725M 350.06M 2026-03